Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gallus

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 12, 2014
Thrombosis: a major contributor to global disease burdenG E Raskob, P Angchaisuksiri, A N Blanco, et al.
The New England Journal of Medicine|October 31, 2003
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolismH R Büller, B L Davidson, H Decousus, et al.
Journal of Thrombosis and Haemostasis : JTH|April 9, 2015
Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosisS Schulman, M Zondag, L Linkins, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Arteriosclerosis, Thrombosis, and Vascular Biology|October 12, 2014
Thrombosis: a major contributor to global disease burdenG E Raskob, P Angchaisuksiri, A N Blanco, et al.
The New England Journal of Medicine|October 31, 2003
Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolismH R Büller, B L Davidson, H Decousus, et al.
Journal of Thrombosis and Haemostasis : JTH|April 9, 2015
Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosisS Schulman, M Zondag, L Linkins, et al.
Pageof 3